isabelobrien, Author at European Medical Journal - Page 55 of 66

How to build a disease awareness campaign remotely

The disruptor that is COVID-19 has turned everything upside down, including disease awareness campaigns. GOLD catches up with pharma marketing experts to see how they have adapted to their circumstances.

Talking to Emily Pegg

Dr Emily Pegg, Head of Medical Affairs UK, Takeda Oncology, discusses how pharma’s relationship with HCPs is evolving.

Talking to Timothy White

Timothy White, Vice President and Head of Global Digital Commercial, Teva Pharmaceuticals, discusses the subject of digital transformation.

Talking to Paul Simms

Paul Simms, Chief Executive, Impatient Health, discusses the importance of overcoming red tape in pursuit of innovation.

Talking to Rob Jekielek

Rob Jekielek, Managing Director, The Harris Poll, discusses the evolving public perceptions of the pharma industry.

Talking to José Maria Guido Avila

José Maria Guido Avila, Global Lead HCP Marketing, Sanofi, shares his thoughts on appropriate metrics measure the success of virtual events.

Talking to Ipsen's UK & Ireland team

Four Ipsen colleagues discuss the fabric and value of high-performing teams, especially against the backdrop of COVID-19.

Was the pandemic the rebrand pharma needed?

The pharmaceutical industry has long struggled with its reputation, but 2020 offered an opportunity for reform. How has their response to the crisis affected perceptions, or is misinformation still getting in the way?

Securing patient care beyond COVID-19

While attention was channelled into COVID-19, patients awaiting other treatments were deprioritised. How can pharma ensure no patients are left behind?

Roundtable: a conversation about drug pricing

Hear from two thought leaders who share their passion for health economics, their thoughts on non-traditional models, and how they predict drugs will be costed in the future.